Go Back   NeuroTalk Communities > Health & Related Topics > Dentistry & Dental Issues

Dentistry & Dental Issues For support and discussion about dentistry and dental issues.

CJD: update for dental staff

Reply
 
Thread Tools Display Modes
Old 04-19-2007, 11:28 AM   #1
flounder
Junior Member
 
Join Date: Feb 2007
Location: Bacliff, Texas
Posts: 48
Help (DH) Precautionary advice given to dentists on vCJD

(DH) Precautionary advice given to dentists on vCJD
Thu Apr 19, 2007 11:11
70.110.92.6


19/04/2007 10:14


Department of Health (National)

(DH) Precautionary advice given to dentists on re-use of instruments


As a precautionary measure the Chief Dental Officer, Dr Barry Cockcroft today issued new guidance to all dentists in England regarding single use of reamers and files, instruments used only in the root filling of teeth.

The guidance to dentists follows on from precautionary advice from the Spongiform Encephalopathy Advisory Committee to the Department of Health and early results from ongoing research conducted by the Health Protection Agency, indicating a potential risk of vCJD associated with endodontic procedures.

Dr Barry Cockcroft said:

"There are no reported definite or suspected cases of vCJD transmission arising from dental procedures - this new guidance to dentists is purely an extra precaution. The public should continue to attend their dentist as normal."

Notes to Editors:

1. The guidance applies to all primary and secondary care dentists in England.

2. Endodontics relate to treatment to the dental pulp of a tooth. A major part of this is root canal work. No other aspect of dental work is affected by this precautionary advice.

3. There are approximately 1 million NHS endodontic treatments every year in England and Wales. Since 1996 there have been 165 cases of vCJD. There is no current evidence of vCJD being transmitted by any form of dentistry.

4. Variant Creutzfeldt-Jakob Disease (vCJD) is one of the Transmissible Spongiform Encephalopathies, the group of prion diseases that include Bovine Spongiform Encephalopathy (BSE), Creutzfeldt-Jakob Disease (CJD), and scrapie.

5. This letter reflects precautionary advice from the Spongiform Encephalopathy Advisory Committee (SEAC) and early results on the potential infectivity of dental tissues from research in progress by the Health Protection Agency. This research supports the view that dental instruments (files and reamers) used in root canal treatment could possibly pose an effective route of vCJD transmission.

6. Almost everyone is at some risk of being infected with vCJD due to dietary exposure to BSE. Any additional risk from a root canal treatment could only arise if the instruments had been previously used on an infective patient. The proportion of people carrying infection is highly uncertain. Published information suggests that this may be between 1 in 1,400 and 1 in 20,000 people, though it may well be less for some age groups. It is also not clear how many of those carrying the infection are likely to develop symptoms of vCJD: given the much smaller number of cases actually seen so far, the majority may never do so (Clarke and Ghani, 2005). Even if instruments had been used on someone carrying the infection, it is not clear how great the risk of vCJD being passed on would be. Nevertheless, a precautionary approach is justified in view of the number of endodontic procedures carried out.

[ENDS]

Client ref 2007/0092

GNN ref 146384P



===============================================


PLEASE SEE DENTAL RISK FROM HUMAN AND ANIMAL TSE


http://neurotalk.psychcentral.com/ar...p/t-13173.html


http://disc.server.com/discussion.cg...USSION%20BOARD




http://www.rense.com/general34/evi.htm




Subject: MASTER DENTIST FALLS VICTIM TO CJD
Date: March 31, 2007 at 1:27 pm PST


http://lists.ifas.ufl.edu/cgi-bin/wa...net-mg&P=19835




COULD A CJD QUESTIONNAIRE TO EVERY FAMILY OF A VICTIM HELP ???

http://brain.hastypastry.net/forums/...ead.php?t=2408



USA MAD COW STRAIN MORE VIRULENT TO HUMANS THAN UK STRAIN

18 January 2007 - Draft minutes of the SEAC 95 meeting (426 KB) held on 7
December 2006 are now available.


snip...


64. A member noted that at the recent Neuroprion meeting, a study was
presented showing that in transgenic mice BSE passaged in sheep may be more
virulent and infectious to a wider range of species than bovine derived BSE.

Other work presented suggested that BSE and bovine amyloidotic spongiform
encephalopathy (BASE) MAY BE RELATED. A mutation had been identified in the
prion protein gene in an AMERICAN BASE CASE THAT WAS SIMILAR IN NATURE TO A
MUTATION FOUND IN CASES OF SPORADIC CJD.


snip...


http://www.seac.gov.uk/minutes/95.pdf



3:30 Transmission of the Italian Atypical BSE (BASE) in Humanized Mouse

Models Qingzhong Kong, Ph.D., Assistant Professor, Pathology, Case Western Reserve
University

Bovine Amyloid Spongiform Encephalopathy (BASE) is an atypical BSE strain
discovered recently in Italy, and similar or different atypical BSE cases
were also reported in other countries. The infectivity and phenotypes of
these atypical BSE strains in humans are unknown. In collaboration with
Pierluigi Gambetti, as well as Maria Caramelli and her co-workers, we have
inoculated transgenic mice expressing human prion protein with brain
homogenates from BASE or BSE infected cattle. Our data shows that about half
of the BASE-inoculated mice became infected with an average incubation time
of about 19 months; in contrast, none of the BSE-inoculated mice appear to
be infected after more than 2 years.

***These results indicate that BASE is transmissible to humans and suggest that BASE is more virulent than
classical BSE in humans.***


6:30 Close of Day One


http://www.healthtech.com/2007/tse/day1.asp



SEE STEADY INCREASE IN SPORADIC CJD IN THE USA FROM
1997 TO 2006. SPORADIC CJD CASES TRIPLED, with phenotype
of 'UNKNOWN' strain growing. ...


http://www.cjdsurveillance.com/resou...asereport.html




There is a growing number of human CJD cases, and they were presented last
week in San Francisco by Luigi Gambatti(?) from his CJD surveillance
collection.

He estimates that it may be up to 14 or 15 persons which display selectively
SPRPSC and practically no detected RPRPSC proteins.


http://www.fda.gov/ohrms/dockets/ac/...006-4240t1.htm


http://www.fda.gov/ohrms/dockets/ac/...006-4240t1.pdf


Thursday, March 15, 2007

Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD)
From Plasma-Derived Products

In recent years, questions have been raised concerning the potential risk of variant Creutzfeldt-Jakob disease (vCJD - a rare but fatal brain infection) for recipients of plasma- derived clotting factors, including United States (US) licensed Factor Eight (pdFVIII), Factor Nine (pdFIX), and other plasma-derived products such as immune globulins and albumin. In response to these questions, FDA conducted a risk assessment. Based on the risk assessment, the US Public Health Service believes that the risk of vCJD to patients who receive US licensed pdFVIII products is most likely to be extremely small, although we do not know the risk with certainty. vCJD risk from other plasma derived products, including Factor IX, is likely to be as small or smaller.

This web page provides FDA’s risk assessment for US licensed pdFVIII and risk communication materials for this product and other plasma derivatives. Included are Key Points, and Questions and Answers. Additional links are provided to FDA’s current guidance documents on deferral of blood and plasma donors who may be at increased risk of vCJD, and to other sources of information regarding vCJD.

Documents Regarding US Licensed pdFVIII, and Other US Licensed Plasma Derivatives Including pdFIX

Potential vCJD Risk From US Licensed Plasma-Derived Factor VIII (pdFVIII, Antihemophilic Factor) Products: Summary Information, Key Points
Risk Assessment (PDF, 582 KB)
Risk Assessment Appendix (PDF, 623 KB)
Questions and Answers on vCJD and pdFVIII
Questions and Answers on vCJD and Plasma Derivatives Other than pdFVIII
Guidance on Donor Deferral Related to CJD and vCJD

Draft Guidance for Industry: Amendment (Donor Deferral for Transfusion in France Since 1980) to "Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products" - 8/2006
Questions and Answers on FDA Guidance: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob (CJD) Disease and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products - 1/22/2004
Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products - 1/2002
Other Sources of Information

Transmissible Spongiform Encephalopathies Advisory Committee
Blood Products Advisory Committee Meeting – Summary of Recent TSEAC Meeting and Statement about FXI from the UK, on October 21, 2004
Information on vCJD: Centers for Disease Control and Prevention
Information on Bovine Spongiform Encephalopathy (“Mad Cow Disease”): US Department of Agriculture
Patient Organizations:

Committee of Ten Thousand
Hemophilia Federation of America
National Hemophilia Foundation and/or HANDI
World Federation of Hemophilia

http://www.fda.gov/cber/blood/vcjdrisk.htm




PRODUCT
Recovered Plasma, Recall # B-0854-07
CODE
Unit: V10665
RECALLING FIRM/MANUFACTURER
Virginia Blood Services, Richmond, VA, by email on August 25, 2004. Firm initiated recall is complete.
REASON
Blood product, collected from a donor who was at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
VOLUME OF PRODUCT IN COMMERCE
1 unit
DISTRIBUTION
Switzerland


END OF ENFORCEMENT REPORT FOR MARCH 14, 2007

###


http://www.fda.gov/bbs/topics/enforc.../ENF00995.html




nvCJD mad cow blood recalls ENFORCEMENT REPORT FOR MARCH 7, 2007

___________________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced, Recall # B-0805-07;
b) Platelets, Recall # B-0806-07;
c) Recovered Plasma, Recall # B-0807-07
CODE
a) Units: 4759943, 4677574, 4555912;
b) Units: 4759943, 4555912;
c) Units: 4677574, 4555912
RECALLING FIRM/MANUFACTURER
Oklahoma Blood Institute, Sylvan N. Goldman Center, Oklahoma City, OK, by facsimile on May 20, 2005. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new variant Creutzfeldt-Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
7 units
DISTRIBUTION
MA, OK, TX, and Switzerland

___________________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced, Recall # B-0808-07;
b) Platelets, Recall # B-0809-07;
c) Recovered Plasma, Recall # B-0810-07
CODE
a), b), and c) Unit: 5249546
RECALLING FIRM/MANUFACTURER
Oklahoma Blood Institute, Sylvan N, Goldman Center, Oklahoma City, OK, by facsimile on August 1, 2005. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new variant Creutzfeldt-Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
3 units
DISTRIBUTION
OK, NB, and Switzerland

___________________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced, Recall # B-0811-07;
b) Recovered Plasma, Recall # B-0812-07
CODE
a) and b) Unit: 5218775
RECALLING FIRM/MANUFACTURER
Oklahoma Blood Institute, Sylvan N, Goldman Center, Oklahoma City, OK, by facsimile on July 7, 2005. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new variant Creutzfeldt-Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
2 units
DISTRIBUTION
OK and Switzerland

___________________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced, Recall # B-0826-07;
b) Platelets, Recall # B-0827-07;
c) Fresh Frozen Blood, Recall # B-0828-07;
d) Recovered Plasma, Recall # B-0829-07
CODE
a) Units: 5250527, 4901850, 4517058;
b) Units: 4901850, 4517058;
c) Unit: 4517058;
d) Units: 5250527, 4901850
RECALLING FIRM/MANUFACTURER
Oklahoma Blood Institute, Sylvan N. Goldman Center, Oklahoma City, OK, by facsimile on March 27, 2006. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new variant Creutzfeldt-Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
8 units
DISTRIBUTION
OK, TX, Austria, and Switzerland

___________________________________

PRODUCT
a) Red Blood Cells, Leukocytes Reduced, Recall # B-0843-07;
b) Recovered Plasma, Recall # B-0844-07
CODE
a) and b) Units: 5738052, 5275313, 4801421
RECALLING FIRM/MANUFACTURER
Oklahoma Blood Institute, Sylvan N. Goldman Center, Oklahoma City, OK, by facsimile on January 22, 2006. Firm initiated recall is complete.
REASON
Blood products, collected from a donor who was at increased risk for new variant Creutzfeldt-Jakob Disease (nvCJD), were distributed.
VOLUME OF PRODUCT IN COMMERCE
6 units
DISTRIBUTION
TX, OK, and Switzerland

END OF ENFORCEMENT REPORT FOR MARCH 7, 2007

###

http://www.fda.gov/bbs/topics/enforc.../ENF00994.html



4th CASE VCJD VIA BLOOD TRANSFUSION, BSE, BASE, AND SPORADIC CJD

By Terry S Singeltary

Bacliff, Texas USA Jan 24, 07


http://bloodindex.org/view_news_zone.php?id=206


PDF]Freas, William TSS SUBMISSION

File Format: PDF/Adobe Acrobat -

Page 1. J Freas, William From: Sent: To: Subject: Terry S. Singeltary

Sr. [flounder@wt.net] Monday, January 08,200l 3:03 PM freas ...


http://www.fda.gov/ohrms/dockets/ac/.../3681s2_09.pdf


----- Original Message -----
From: Terry S. Singeltary Sr.
To: Terry S. Singeltary Sr. ; [log in to unmask]
Cc: [log in to unmask] ; [log in to unmask]
Sent: Thursday, November 30, 2006 1:47 PM
Subject: Re: TSE advisory committee for the meeting December 15, 2006 [TSS SUBMISSION PART II]


http://lists.ifas.ufl.edu/cgi-bin/wa...mg&T=0&P=16159




TSS
flounder is offline   Reply With Quote
Old 06-09-2007, 11:10 AM   #2
flounder
Junior Member
 
Join Date: Feb 2007
Location: Bacliff, Texas
Posts: 48
Help Position Statement vCJD and Dentistry SEAC

SEAC
Position Statement

--------------------------------------------------------------------------------

Position Statement vCJD and Dentistry
Issue
1. The Department of Health (DH) asked SEAC to advise on the findings of preliminary research aimed at informing estimates of the risk of variant Creutzfeldt-Jakob Disease (vCJD) transmission via dentistry.

Background
2. Prions are more resistant than other types of infectious agent to the conventional cleaning and sterilisation practices used to decontaminate dental instruments1. Appreciable quantities of residual material may remain adherent to the surface after normal cleaning and sterilisation2. Therefore, if dental tissues are both infectious and susceptible to infection, then dental instruments are a potential mechanism for the secondary transmission of vCJD. Dentistry could be a particularly significant route of transmission for the population as a whole, due to the large number of routine procedures undertaken and also because dental patients have a normal life expectancy. This is in contrast with other transmission routes, such as blood transfusion and neurosurgery, where procedures are often carried out in response to some life-threatening condition. Additionally, the ubiquity of dental procedures and the lack of central records on dental procedures means that should such transmission occur, then it would be difficult to detect and control.

3. No cases of vCJD transmission arising from dental procedures have been reported to date 3 . Previous DH risk assessments4,5 have focused on two possible mechanisms for the transfer of vCJD infectivity via dental instruments; accidental abrasion of the lingual tonsil and endodontic procedures that involve contact with dental pulp. In considering these assessments, SEAC agreed that the risk of transmission via accidental abrasion of the lingual tonsil appears very low. However, the risk of transmission via endodontic procedures may be higher and give rise to a self sustaining vCJD epidemic under circumstances where (i) dental pulp is infective, (ii) transmission via endodontic instruments is efficient and (iii) a large proportion of vCJD infections remain in a subclinical carrier state (SEAC 91, February 2006). In light of this, SEAC advised that restricting endodontic files and reamers to single use be considered 6. SEAC recommended reassessment of these issues as new data emerge.

New research
4. Preliminary, unpublished results of research from the Health Protection Agency, aimed at addressing some of the uncertainties in the risk assessments, were reviewed by SEAC (SEAC 97, May 2007). The prion agent used in these studies is closely related to the vCJD agent. This research, using a mouse model, shows that following inoculation of mouse-adapted bovine spongiform encephalopathy (BSE) directly into the gut, infectivity subsequently becomes widespread in tissues of the oral cavity, including dental pulp, salivary glands and gingiva, during the preclinical as well as clinical stage of disease.

5. It is not known how closely the level and distribution of infectivity in the oral cavity of infected mice reflects those of humans infected with vCJD, as there are no comparable data from oral tissues, in particular dental pulp and gingiva, from human subclinical or clinical vCJD cases7. Although no abnormal prion protein was found in a study of human dental tissues, including dental pulp, salivary glands and gingiva from vCJD cases , the relationship between levels of infectivity and abnormal prion protein is unclear8. Infectivity studies underway using the mouse model and oral tissues that are presently available from human vCJD cases will provide some comparable data. On the basis of what is currently known, there is no reason to suppose that the mouse is not a good model for humans in respect to the distribution of infectivity in oral tissues. Furthermore, the new data are consistent with published results from experiments using a hamster scrapie model9 .

6. A second set of experiments using the same mouse model showed that non-invasive and transient contact between gingival tissue and fine dental files contaminated with mouse-adapted BSE brain homogenate transmits infection very efficiently. It is not known how efficient gingival transmission would be if dental files were contaminated with infectious oral tissues and then subsequently cleaned and sterilised, a situation which would more closely model human dental practice. Further studies using the mouse model that would be more representative of the human situation, comparing oral tissues with a range of doses of infectivity, cleaned and sterilised files and the kind of tissue contact with instruments that occurs during dentistry, should be considered.

7. SEAC considered that the experiments appear well designed and the conclusions justified and reliable, while recognising that the research is incomplete and confirmatory experiments have yet to be completed. It is recommended that the research be completed, submitted for peer-review and widely disseminated as soon as possible so others can consider the implications. Nevertheless, these preliminary data increase the possibility that some oral tissues of humans infected with vCJD may potentially become infective during the preclinical stage of the disease. In addition, they increase the possibility that infection could potentially be transmitted not only via accidental abrasion of the lingual tonsil or endodontic procedures but a variety of routine dental procedures. Implications for transmission risks

8. The new findings help refine assumptions made about the level of infectivity of dental pulp and the stage of incubation period when it becomes infective in the risk assessment of vCJD transmission from the reuse of endodontic files and reamers10. For example, if one patient in 10 000 were to be carrying infection (equivalent to about 6 000 people across the UK – the best current estimate11), the data suggest that in the worst case scenario envisaged in the risk assessment, re-use of endodontic files and reamers might lead to up to 150 new infections per annum. It is not known how many of those infected would go on to develop clinical vCJD. In addition, transmission via the re-use of endodontic files and reamers could be sufficiently efficient to cause a self-sustaining vCJD epidemic arising via this route.

9. These results increase the importance of obtaining reliable estimates of vCJD infection prevalence. Data that will soon be available from the National Anonymous Tonsil Archive may help refine this assessment and provide evidence of the existence and extent of subclinical vCJD infection in tonsillectomy patients. Further data, such as from post mortem tissue or blood donations, will be required to assess prevalence in the general UK population12.

10. Recent guidance issued by DH to dentists to ensure that endodontic files and reamers are treated as single use13 is welcomed and should, as long as it is effectively and quickly implemented, prevent transmission and a self-sustaining epidemic arising via this route. However, the extent and monitoring of compliance with this guidance in private and National Health Service dental practice is unclear.

11. The new research also suggests that dental procedures involving contact with other oral tissues, including gingiva, may also be capable of transmitting vCJD. In the absence of a detailed risk assessment examining the potential for transmission via all dental procedures, it is not possible to come to firm conclusions about the implications of these findings for transmission of vCJD. However, given the potential for transmission by this route serious consideration should be given to assessing the options for reducing transmission risks such as improving decontamination procedures and practice or the implementation of single use instruments.

12. The size of the potential risk from interactions between the dental and other routes of secondary transmission, such as blood transfusion and hospital surgery, to increase the likelihood of a self-sustaining epidemic is unclear.

13. It is likely to be difficult to distinguish clinical vCJD cases arising from dietary exposure to BSE from secondary transmissions via dental procedures, should they arise, as a large proportion of the population is likely both to have consumed contaminated meat and undergone dentistry. However, an analysis of dental procedures by patient age may provide an indication of the age group in which infections, if they occur, would be most likely to be observed. Should the incidence of clinical vCJD cases in this age group increase significantly, this may provide an indication that secondary transmission via dentistry is occurring. Investigation of the dental work for these cases may provide supporting data. There is no clear evidence, to date, based on surveillance or investigations of clinical vCJD cases, that any vCJD cases have been caused by dental procedures but this possibility cannot be excluded.

Conclusions
14. Preliminary research findings suggest that the potential risk of transmission of vCJD via dental procedures may be greater than previously anticipated. Although this research is incomplete, uses an animal model exposed to relatively high doses of infectivity, and there are no data from infectivity studies on human oral tissues, these findings suggest an increased possibility that vCJD may be relatively efficiently transmitted via a range of dental procedures. Ongoing infectivity studies using human oral tissues and the other studies suggested here will enable more precise assessment of the risks of vCJD transmission through dental procedures.

15. Guidance was issued to dentists earlier this year recommending that endodontic files and reamers be treated as single use which, provided it is adhered to, will remove any risk of a self-sustaining epidemic arising from re-use of these instruments. To minimise risk it is critical that appropriate management and audit is in place, both for NHS and private dentistry.

16. It is also critical that a detailed and comprehensive assessment of the risks of all dental procedures be conducted as a matter of urgency. While taking into account the continuing scientific uncertainties, this will allow a more thorough consideration of the possible public health implications of vCJD transmission via dentistry and the identification of possible additional precautionary risk reduction measures. The assessment will require continued updating as more evidence becomes available on the transmissibility of vCJD by dental routes, and on the prevalence of infection within the population. A DH proposal to convene an expert group that includes dental professionals to expedite such an assessment is welcomed. Given the potential for transmission via dentistry, consideration should be given to the urgent assessment of new decontamination technologies which, if proved robust and effective, could significantly reduce transmission risks.



SEAC
June 2007



References
1Smith et al. (2003) Prions and the oral cavity. J. Dent. Res. 82, 769-775.

2Smith et al. (2005) Residual protein levels on reprocessed dental instruments. J. Hosp. Infect. 61, 237-241.

3Everington et al. (2007) Dental treatment and risk of variant CJD – a case control study. Brit. Den. J. 202, 1-3.

4Department of Health. (2003) Risk assessment for vCJD and dentistry.

5 Department of Health (2006) Dentistry and vCJD: the implications of a carrier-state for a self-sustaining epidemic. Unpublished.

6SEAC (2006) Position statement on vCJD and endodontic dentistry. http://www.seac.gov.uk/statements/statement0506.htm

7Head et al. (2003) Investigation of PrPres in dental tissues in variant CJD. Br. Dent. J. 195, 339-343.

8SEAC 90 reserved business minutes.

9Ingrosso et al. (1999) Transmission of the 263K scrapie strain by the dental route. J. Gen. Virol. 80, 3043-3047.

10Department of Health (2006) Dentistry and vCJD: the implications of a carrier-state for a self-sustaining epidemic. Unpublished.

11Clarke & Ghani (2005) Projections of future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility R. J. Soc. Interface. 2, 19-31.

12SEAC Epidemiology Subgroup (2006) position statement of the vCJD epidemic. http://www.seac.gov.uk/statements/st...06subgroup.htm

13DH (2007) Precautionary advice given to dentists on re-use of instruments http://www.gnn.gov.uk/environment/fu...partment=False



Page updated: 8 June, 2007


http://www.seac.gov.uk/statements/st...-dentrstry.htm


USA MAD COW STRAIN MORE VIRULENT TO HUMANS THAN UK STRAIN

18 January 2007 - Draft minutes of the SEAC 95 meeting (426 KB) held on 7
December 2006 are now available.


snip...

64. A member noted that at the recent Neuroprion meeting, a study was
presented showing that in transgenic mice BSE passaged in sheep may be more
virulent and infectious to a wider range of species than bovine derived BSE.

Other work presented suggested that BSE and bovine amyloidotic spongiform
encephalopathy (BASE) MAY BE RELATED. A mutation had been identified in the
prion protein gene in an AMERICAN BASE CASE THAT WAS SIMILAR IN NATURE TO A
MUTATION FOUND IN CASES OF SPORADIC CJD.


snip...

http://www.seac.gov.uk/minutes/95.pdf


3:30 Transmission of the Italian Atypical BSE (BASE) in Humanized Mouse

Models Qingzhong Kong, Ph.D., Assistant Professor, Pathology, Case Western
Reserve
University

Bovine Amyloid Spongiform Encephalopathy (BASE) is an atypical BSE strain
discovered recently in Italy, and similar or different atypical BSE cases
were also reported in other countries. The infectivity and phenotypes of
these atypical BSE strains in humans are unknown. In collaboration with
Pierluigi Gambetti, as well as Maria Caramelli and her co-workers, we have
inoculated transgenic mice expressing human prion protein with brain
homogenates from BASE or BSE infected cattle. Our data shows that about half
of the BASE-inoculated mice became infected with an average incubation time
of about 19 months; in contrast, none of the BSE-inoculated mice appear to
be infected after more than 2 years.

***These results indicate that BASE is transmissible to humans and suggest
that BASE is more virulent than
classical BSE in humans.***


6:30 Close of Day One


http://www.healthtech.com/2007/tse/day1.asp


SEE STEADY INCREASE IN SPORADIC CJD IN THE USA FROM
1997 TO 2006. SPORADIC CJD CASES TRIPLED, with phenotype
of 'UNKNOWN' strain growing. ...


http://www.cjdsurveillance.com/resou...asereport.html

There is a growing number of human CJD cases, and they were presented last
week in San Francisco by Luigi Gambatti(?) from his CJD surveillance
collection.

He estimates that it may be up to 14 or 15 persons which display selectively
SPRPSC and practically no detected RPRPSC proteins.


http://www.fda.gov/ohrms/dockets/ac/...006-4240t1.htm


http://www.fda.gov/ohrms/dockets/ac/...006-4240t1.pdf


Diagnosis and Reporting of Creutzfeldt-Jakob Disease

Singeltary, Sr et al. JAMA.2001; 285: 733-734.

http://jama.ama-assn.org/http://www....s/60/2/176#535

BRITISH MEDICAL JOURNAL


BMJ


vCJD in the USA * BSE in U.S.
15 November 1999


http://www.bmj.com/cgi/eletters/319/7220/1312/b#5406


BMJ


U.S. Scientist should be concerned with a CJD epidemic in the U.S., as
well...
2 January 2000


http://www.bmj.com/cgi/eletters/320/7226/8/b#6117

JOURNAL OF NEUROLOGY

MARCH 26, 2003

RE-Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob

disease in the United States

Email Terry S. Singeltary:

flounder@wt.net

I lost my mother to hvCJD (Heidenhain Variant CJD). I would like to

comment on the CDC's attempts to monitor the occurrence of emerging

forms of CJD. Asante, Collinge et al [1] have reported that BSE

transmission to the 129-methionine genotype can lead to an alternate

phenotype that is indistinguishable from type 2 PrPSc, the commonest

sporadic CJD. However, CJD and all human TSEs are not reportable

nationally. CJD and all human TSEs must be made reportable in every

state and internationally. I hope that the CDC does not continue to

expect us to still believe that the 85%+ of all CJD cases which are

sporadic are all spontaneous, without route/source. We have many TSEs in

the USA in both animal and man. CWD in deer/elk is spreading rapidly and

CWD does transmit to mink, ferret, cattle, and squirrel monkey by

intracerebral inoculation. With the known incubation periods in other

TSEs, oral transmission studies of CWD may take much longer. Every

victim/family of CJD/TSEs should be asked about route and source of this

agent. To prolong this will only spread the agent and needlessly expose

others. In light of the findings of Asante and Collinge et al, there

should be drastic measures to safeguard the medical and surgical arena

from sporadic CJDs and all human TSEs. I only ponder how many sporadic

CJDs in the USA are type 2 PrPSc?

http://www.neurology.org/cgi/eletters/60/2/176#535


doi:10.1016/S1473-3099(03)00715-1
Copyright © 2003 Published by Elsevier Ltd.
Newsdesk

Tracking spongiform encephalopathies in North America

Xavier Bosch

Available online 29 July 2003.


Volume 3, Issue 8, August 2003, Page 463


“My name is Terry S Singeltary Sr, and I live in Bacliff, Texas. I lost my
mom to hvCJD (Heidenhain variant CJD)
and have been searching for answers ever since. What I have found is that we
have not been told the truth. CWD
in deer and elk is a small portion of a much bigger problem.”
............................


http://www.thelancet.com/journals/la...07151/fulltext

http://download.thelancet.com/pdfs/j...9903007151.pdf


see history of cjd questionnaire

http://brain.hastypastry.net/forums/...ead.php?t=2408

sporadic CJD, the big lie

http://lists.ifas.ufl.edu/cgi-bin/wa...mg&T=0&P=25276


TSS
flounder is offline   Reply With Quote
Old 06-10-2007, 04:17 PM   #3
Bryanna
Member
 
Join Date: Feb 2007
Posts: 555
My Mood:
Default

TSS,
Lots to read! What it truly comes down to is quite simple....... proper sterilization techniques MUST be done under ALL circumstances, ALL of the time, in ALL dental and medical facilities. Precaution should be taken to not just minimize, but eliminate the possibility of contamination to the patients and the staff.

Having been in dentistry for 30 yrs......... I can without any doubt say that proper sterilization techniques are not carried out 100% of the time. The only way to do that is to have one very dedicated (or more) staff member whose only job is to clean up and sterilize the operatories/exam rooms and instruments. This cannot be done efficiently or effectively by the staff member who also assists the doctor if she/he is responsible for keeping a tight schedule and has to be in 2 (or more) places at one time.

Contamination from a doctor, staff member, dirty instrument or other operatory source is completely avoidable if the proper protocols are put forth, utilized and enforced.

Thanks for posting these articles!
Bryanna
Bryanna is offline   Reply With Quote
Old 07-13-2007, 05:57 PM   #4
flounder
Junior Member
 
Join Date: Feb 2007
Location: Bacliff, Texas
Posts: 48
Help

Subject: Pre-sterilisation cleaning of re-usable instruments (TSE)
Date: July 13, 2007 at 2:24 pm PST

Pre-sterilisation cleaning of re-usable instruments
in general dental practice

J. Bagg,1 A. J. Smith,2 D. Hurrell,3 S. McHugh4 and G. Irvine5
Objective This study examined the policies, procedures, environment
and equipment used for the cleaning of dental instruments in general
dental practice.

Materials and methods A total of 179 surgeries were surveyed. This
was an observational based study in which the cleaning processes
were viewed directly by a trained surveyor. Information relating to
surgery policies and equipment was also collected by interview and
viewing of records. Data were recorded onto a standardised data collection
form prepared for automated reading.
Results The BDA advice sheet A12 was available in 79% of surgeries
visited. The most common method for cleaning dental instruments
was manual washing, with or without the use of an ultrasonic bath.
Automated washer disinfectors were not used by any surgery visited.
The manual wash process was poorly controlled, with 41% of practices
using no cleaning agent other than water. Only 2% of surgeries used
a detergent formulated for manual washing of instruments. When
using ultrasonic baths, the interval that elapsed between changes of
the ultrasonic bath cleaning solution ranged from two to 504 hours
(median nine hours). Fifty-eight percent of surgeries claimed to have
a dedicated area for instrument cleaning, of which 80% were within
the patient treatment area. However, in 69% of surgeries the clean
and dirty areas were not clearly defi ned. Virtually all cleaning of dental
instruments was undertaken by dental nurses. Training for this was
provided mainly by demonstration and observed practice of a colleague.
There was little documentation associated with training. Whilst
most staff wore gloves when undertaking manual cleaning, 51% of
staff did not use eye protection, 57% did not use a mask and 7% used
waterproof overalls.

Conclusions

In many dental practices, the cleaning of re-usable
dental instruments is undertaken using poorly controlled processes
and procedures, which increase the risk of cross infection. Clear and
unambiguous advice must be provided to the dental team, especially
dental nurses, on appropriate equipment, chemicals and environment
for cleaning dental instruments. This should be facilitated by appropriate
training programmes and the implementation of quality assurance
procedures at each stage of the cleaning process.


INTRODUCTION

The decontamination of re-usable medical devices is a key element
of infection control in clinical settings. The importance
of cleaning such devices as a means of preventing cross infection
has been reported in relation to diverse items of equipment
in many areas of clinical practice. These have included
ophthalmology,1 gastroenterology,2 vascular surgery,3 tourniquets4
and dental surgery.5-9
More recently, the emergence of transmissible spongiform
encephalopathies (TSEs), such as variant Creutzfeldt-Jakob
disease (vCJD), has re-emphasised the importance of thorough
cleaning of used devices prior to steam sterilisation10,11
since the abnormal form of prion protein, which is responsible
for these diseases, is less susceptible to denaturation by heat.
Thus, effi cient cleaning of instruments is believed to be a key
procedure for reducing the potential risks of onward transmission
of vCJD.10-12 Effective cleaning is also vital to ensure
microbial inactivation since retention of organic or inorganic
debris may compromise subsequent disinfection or sterilization
processes.13-16 The cleaning of re-usable dental instruments is
also important to ensure device longevity and functionality,
removal of chemical residues and compliance with medicolegal
directives.17-19
One mechanism for improving the quality of instrument
decontamination is to centralise re-processing in
well-equipped sterile services departments, which are operated
by highly trained staff, using validated equipment, in
an accredited quality management system. In the UK, this
approach has been applied in the acute hospital sector. The
problem with this centralised model in dentistry is that the
high volume of instruments used by dental surgeons provides
a signifi cant logistical challenge. It is therefore likely that
instrument decontamination in general dental practice will
continue to be undertaken at a local level. It is important that
all processes involved in decontamination are undertaken to
a high standard, but unfortunately there has been little evidence
to indicate the robustness of these procedures in dental
practice, as highlighted in a systematic review.20 In order to
address this problem, a large observational study of decontamination
procedures in general dentistry in Scotland was
devised and has recently been completed. This paper reports
the data generated by the study in relation to procedures used
by dentists for pre-cleaning of instruments prior to the sterilisation
phase.

MATERIALS AND METHODS

snip. ...

In conclusion, many of the procedures used for the cleaning
of re-usable dental instruments in general dental practice
do not conform to extant guidance and increase the risk
of transmission of infection. This is of particular concern,
since cleaning is a key stage in the sterilisation process and in
reducing the risk from onward transmission of vCJD. Where
possible, practices should review the many options available
to them for the reprocessing of dental instruments. In some
circumstances this may involve the use of centralised reprocessing
facilities35 or single use instruments. Other options may
involve a compromise with local reprocessing of expensive
devices such as dental handpieces and centralised reprocessing
of other instruments. If local reprocessing of dental instruments
is to continue in general dental practice, clearly much
work is needed to help the dental team improve the cleaning
process for dental instruments. This should take the form of
education and training programmes and the development of
a clearer management process using quality assurance principles.
The fi ndings of this survey also have profound fi nancial
implications for dental practices, not least in the provision of
dedicated decontamination areas and automated washer disinfectors.
This also represents an opportunity for improvement,
especially with the planning of new dental units. However, if
the opportunity is to be fully realised, there is a requirement
for suffi cient infrastructure to support practitioners in implementation
of improvements in local decontamination,29 for
example expert review of new buildings, commissioning and
testing of decontamination equipment. Practice-friendly guidance
to help practitioners meet the various regulatory requirements
for cleaning dental instruments is essential if progress
is to be made in this very important area of clinical practice.
This research was supported by a grant from the Scottish Executive Health
Department. Funding for the training of the survey team members was provided
by NHS Education for Scotland. The authors thank Mr Ray Watkins,
Chief Dental Offi cer for Scotland and Dr Jim Rennie, Postgraduate Dental
Dean for Scotland for support of the study, the members of the survey teams
and the dental practitioners and nurses who agreed to be surveyed.


snip...


full text ;


http://www.nature.com/bdj/journal/v2...j.2007.124.pdf


It is all about motivation

I am occasionally asked by actors and actresses what motivation
their characters have for various lines that I have written
for them in plays and the like. It is a bit of a cliché but there
is usually a good reason for the question as the performer is
attempting to understand their character better and provide an
improved performance for the audience.
But motivation often involves fi nishing the sentence, or at
least the sentiment behind it. In acting it is sometimes forgivable,
indeed sometimes it adds value for the observer when
everything is not spoken or revealed. But there does not seem
to be much of a case for it in health care. I have in mind the
recent advice issued by the various UK Departments of Health
in relation to the single-use of endodontic instruments.
One has to assume that the information is imparted in good
faith, since why else would a state department issue such advice
(it is advice, note, not guidance or direction). Advice nonetheless
that ‘dentists are expected to follow’? But the manner in
which it was announced and the scientifi c basis on which it is
apparently founded both give rise to suspicions and to distrust.
It is probably just poor logistics but the result is that it opens
the way to questions over motivation.
Firstly to the manner in which it was announced; it transpires
that all policy developments and guidance in relation to vCJD
has to be fi rst reported to Parliament before any other communication
can take place. This was a commitment made by
John Reid when he was Secretary of State for Health and supported
by the then current Ministers. This explains why BDA
members contacted us the same morning of the announcement
asking why the Association had not let them know. We had to
reply that it was because we did not know about it either until
we heard it on BBC Radio 2. Important as it is that 630 MPs
(or however many were in the Chamber that session) are the
fi rst to know, presumably patients in surgeries with the radio
on and endodontic instruments in their root canals would also
think it a matter of some importance. With hindsight, can our
elected representatives really believe that this is the best way
to deal with matters of health care?
The science on which this advice is based brings forth a further
clutch of questions. We are told that, ‘early results from
studies in mice suggest that TSE (Transmissible Spongiform
Encephalopathies, the group of prion diseases that include BSE,
CJD, vCJD and scrapie) infectivity can be found in dental tissues’.
The studies, early results or not, are not published so none
of us can assess that risk independently.
On the one hand this may seem reasonable since we are constantly
being entreated ourselves to follow best practice as
indicated by evidence-based studies. We have to take the Chief
Dental Offi cers’ words at face value, since we have no other
base on which to judge them, as indeed presumably they have
had to take the words of others above them. But on the other
hand this is about calculated risk assessment. Someone, somewhere
has taken a decision on the basis of what is known to
date and the extent to which they assess that to be a threat to
the population. Or in this case a ‘theoretical’ threat. Once again
though, we are denied the knowledge of the motivation. Is the
advice given on a defensive basis so that if in years to come
patients can show that they have contracted a TSE disease from
endodontic treatment they will be able to sue the government
because it failed to act on the scientifi c advice of the time? Or
is the advice given on the basis that such potential litigation
is then passed to the individual dentist? Alternatively, is the
advice just on the basis of taking good care of the population?
It might be all or any of these but we have to guess and it is the
guessing that substantially increases the risk of distrust.
All of this, sadly, obscures what one hopes is the real motivation
behind the advice, which is that if there is a risk then it is
wise to take sensible precautions. The issues of who pays the
additional costs and the environmental questions of reamer and
fi le-mountains all need to be considered in the risk evaluation
too. Have they been? Confl icting reports on the possibility or
not of fi nancial compensation for those dentists offering NHS
dentistry have served only to add further confusion, rumour
and annoyance.
The handling of the matter as a whole makes one seriously
doubt that any kind of global view has been taken before the
advice has been rushed out. We may, as a profession, be accused
of starting to get paranoid about having matters forced upon
us with little or no consultation, little or no notice and precious
little respect for our professionalism but is it really surprising?
Handled logically, with proper sequencing this development
could have been, should have been, a triumph for good sense,
measured response and excellence in health care. Instead it is
an all too familiar shambles. How many more will there be?
Stephen Hancocks OBE
Editor-in-Chief
DOI: 10.1038/bdj.2007.422
It is all about motivation
EDITORIAL
BRITISH DENTAL JOURNAL VOLUME 202 NO. 9 MAY 12 2007


http://www.nature.com/bdj/journal/v2...j.2007.422.pdf


Dental treatment and risk of variant CJD –
a case control study

D. Everington,1 A. J. Smith,2 H. J. T. Ward,3 S. Letters,4 R. G. Will5 and
J. Bagg6

Objective Knowledge of risk factors for variant CJD (vCJD) remains
limited, but transmission of prion proteins via re-useable medical devices,
including dental instruments, or enhanced susceptibility following trauma
to the oral cavity is a concern. This study aimed to identify whether
previous dental treatment is a risk factor for development of vCJD.
Design Case control study.
Methods Risk factor questionnaires completed by interview with
relatives of 130 vCJD patients and with relatives of 66 community and
53 hospital controls were examined by a dental surgeon. Responses
regarding dental treatments were analysed.
Results We did not fi nd a statistically signifi cant excess of risk of vCJD
associated with dental treatments with the exception of extractions in
an unmatched analysis of vCJD cases with community controls
(p = 0.02). However, this result may be explained by multiple testing.
Conclusions This is the fi rst published study to date to examine
potential links between vCJD and dental treatment. There was no
convincing evidence found of an increased risk of variant CJD
associated with reported dental treatment. However, the power of the
study is restricted by the number of vCJD cases to date and does not
preclude the possibility that some cases have resulted from secondary
transmission via dental procedures. Due to the limitations of the data
available, more detailed analyses of dental records are required to fully
exclude the possibility of transmission via dental treatment.


snip...


DISCUSSION

Many studies have searched for risk factors for the development
of different types of CJD, such as diet, exposure to
animals, surgical treatment, including dentistry, and occupational
exposures. A retrospective case control study15 of 60
defi nite cases of sporadic CJD, occurring in Japan between
1975 and 1977 found no association with extractions of maxillary
or mandibular teeth. An analysis of 26 sporadic CJD
cases and 40 matched controls from the United States16 failed
to discover a signifi cant odds ratio for endodontic surgery,
though these workers did note statistically signifi cant odds
ratios for intraocular pressure testing, injury to or surgery on
the head, face or neck and trauma to other parts of the body.
However, these fi ndings suffer from low statistical power and,
in the case of the Japanese paper, information was requested
for extractions only during the fi ve year period prior to onset.
This paper attempts to identify an association between vCJD
and reported dental treatment.
Comparison of the reported dental histories of cases and
controls found that extractions were the only dental risk factor
that reached statistical signifi cance (at the 5% level) in the
unmatched analysis with community controls. This may be a
result of multiple testing especially as there are fewer extractions
in the cases than in the hospital controls. It is likely that
the majority of vCJD cases in this cohort were infected through
eating BSE contaminated meat products. Therefore, it is diffi -
cult to detect a small subgroup that may have been infected by
secondary transmission, as in this study, through dentistry.
There are a number of limitations to this study, most importantly
relying on reported data from relatives and the relatively
small numbers of cases and controls resulting in low
power to detect statistical differences. Recruitment of controls
has been problematic,17 although every effort was made to
maximise this group. Selection of controls was not matched for
demographic and socio-economic factors for dental attendance
and this may have resulted in bias. It is possible that some of
the responses of ‘no known treatment’ refl ect poor knowledge
or recall on the part of the relatives. This would reduce the
power of the study to pick up signifi cant differences between
groups, but not necessarily introduce bias.
Whilst these preliminary data on a topic of great concern
for public health do not provide evidence supporting reported
dental work as being a major route of transmission of the BSE
agent to humans to date, they do not preclude the possibility
that some vCJD cases have been infected by this route.
Furthermore, the incubation period following infection by
a peripheral route may be relatively long and therefore the
period of observation to date of potential secondary transmission
of vCJD may be too short to detect cases.
A more detailed study of previous treatment based on reviewing
actual dental records rather than relying on reported treatments
is required to gain a wider insight into the dental history
of both cases and controls. We are currently investigating the
possibility of examining dental records of vCJD cases and a
larger group of unmatched controls.18

The National CJD Surveillance Unit is funded by the Department of Health
and the Scottish Executive Department of Health. The sponsors of the study
had no role in study design, data collection, data analysis, data
interpretation,
or in the writing of the report. We are also grateful to the families of
cases, without whose co-operation this study would not have been possible.


http://www.nature.com/bdj/journal/v2...j.2007.126.pdf


Subject: Position Statement vCJD and Dentistry SEAC UPDATE DISTURBING
Date: June 9, 2007 at 7:52 am PST


http://disc.server.com/discussion.cg...RD;pagemark=25


http://disc.server.com/discussion.cg...RD;pagemark=25


TSS
flounder is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
TN Caused by Dental Work? phillyinpain Trigeminal Neuralgia 7 01-21-2009 09:33 AM
FDA staff: Adult antidepressant risks differ by age (Reuters) DocJohn Health News Headlines 0 12-05-2006 12:50 PM
Bosses push staff to eat right, exercise (AP) DocJohn Health News Headlines 0 12-04-2006 02:00 PM
New Faculty/Staff Joins Ozark Christian College Family DocJohn Health News Headlines 0 10-26-2006 04:40 AM


All times are GMT -5. The time now is 02:41 PM.
Brought to you by the fine folks who publish mental health and psychology information at Psych CentralMental Health Forums

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider. Always consult your doctor before trying anything you read here.


Powered by vBulletin • Copyright ©2000 - 2009, Jelsoft Enterprises Ltd.


All posts copyright their original authors • Community GuidelinesTerms of UsePrivacy Policy
NeuroTalk Archives